PAINCEPTOR PHARMA CORP has a total of 57 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are VERNALIS CAMBRIDGE LTD, CALASIA PHARMACEUTICALS INC and JANNSEN PHARMACEUTICA N V.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | Canada | 8 | |
#4 | WIPO (World Intellectual Property Organization) | 7 | |
#5 | Brazil | 4 | |
#6 | China | 4 | |
#7 | Republic of Korea | 4 | |
#8 | Australia | 3 | |
#9 | Israel | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Vohra Rahul | 44 |
#2 | Gan Zhonghong | 19 |
#3 | Babinski Kazimierz | 17 |
#4 | Cui Xilin | 15 |
#5 | Ahring Philip K | 15 |
#6 | Gill Nachhattarpal | 14 |
#7 | Wei Chang-Qing | 14 |
#8 | Demnitz Joachim | 12 |
#9 | Auld Daniel Scott | 11 |
#10 | Ntirampebura Deogratias | 7 |
Publication | Filing date | Title |
---|---|---|
US2009082368A1 | Methods of modulating neurotrophin-mediated activity | |
US2009023773A1 | Compositions and methods for modulating gated ion channels | |
US2009246134A1 | Compositions and methods for modulating gated ion channels | |
US2008021034A1 | Compositions and methods for modulating gated ion channels | |
US2008004272A1 | Compositions and methods for modulating gated ion channels | |
EP2010529A1 | Compositions and methods for modulating gated ion channels | |
AU2006329202A1 | Compositions and methods for modulating gated ion channels | |
CA2630617A1 | Compositions and methods for modulating gated ion channels | |
CA2622574A1 | Methods of modulating neurotrophin-mediated activity | |
EP1734962A2 | Compositions and methods for modulating gated ion channels | |
CA2556159A1 | Methods of modulating neurotrophin-mediated activity |